{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:35:31Z","timestamp":1792888531681,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00210-026-05744-5","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T03:02:09Z","timestamp":1784948529000},"page":"21653-21665","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrated bioinformatics analyses and cell line experiments implicate miR-33a-5p\/HIF1A in the cellular response to celastrol in lung adenocarcinoma"],"prefix":"10.1007","volume":"399","author":[{"given":"Yiwei","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyao","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4998-7999","authenticated-orcid":false,"given":"Jiye","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"key":"5744_CR1","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.05005","volume":"4","author":"V Agarwal","year":"2015","unstructured":"Agarwal V, Bell GW, Nam JW, Bartel DP (2015) Predicting effective microRNA target sites in mammalian mRNAs. Elife 4:e05005","journal-title":"Elife"},{"issue":"4","key":"5744_CR2","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1002\/bab.2233","volume":"69","author":"M Asadi","year":"2022","unstructured":"Asadi M, Taghizadeh S, Kaviani E, Vakili O, Taheri-Anganeh M, Tahamtan M, Savardashtaki A (2022) Caspase-3: structure, function, and biotechnological aspects. Biotechnol Appl Biochem 69(4):1633\u20131645","journal-title":"Biotechnol Appl Biochem"},{"key":"5744_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.semcancer.2024.06.003","volume":"102\u2013103","author":"R Bhattacharya","year":"2024","unstructured":"Bhattacharya R, Brown JS, Gatenby RA, Ibrahim-Hashim A (2024) A gene for all seasons: the evolutionary consequences of HIF-1 in carcinogenesis, tumor growth and metastasis. Semin Cancer Biol 102\u2013103:17\u201324","journal-title":"Semin Cancer Biol"},{"issue":"5","key":"5744_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.182","volume":"5","author":"S Boridy","year":"2014","unstructured":"Boridy S, Le PU, Petrecca K, Maysinger D (2014) Celastrol targets proteostasis and acts synergistically with a heat-shock protein 90 inhibitor to kill human glioblastoma cells. Cell Death Dis 5(5):e1216","journal-title":"Cell Death Dis"},{"issue":"3","key":"5744_CR5","first-page":"229","volume":"74","author":"F Bray","year":"2022","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2022) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263","journal-title":"CA Cancer J Clin"},{"issue":"7511","key":"5744_CR6","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nature13385","volume":"511","author":"Cancer Genome Atlas Research Network","year":"2014","unstructured":"Cancer Genome Atlas Research Network (2014) Comprehensive molecular profiling of lung adenocarcinoma. Nature 511(7511):543\u2013550","journal-title":"Nature"},{"issue":"6","key":"5744_CR7","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.3390\/curroncol31060258","volume":"31","author":"MP Capella","year":"2024","unstructured":"Capella MP, Pang SA, Magalhaes MA, Esfahani K (2024) A review of immunotherapy in non-small-cell lung cancer. Curr Oncol 31(6):3495\u20133512","journal-title":"Curr Oncol"},{"issue":"5","key":"5744_CR8","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.cstres.2024.08.002","volume":"29","author":"C Chang","year":"2024","unstructured":"Chang C, Tang X, Woodley DT, Chen M, Li W (2024) Previously unrecognized and potentially consequential challenges facing Hsp90 inhibitors in cancer clinical trials. Cell Stress Chaperones 29(5):642\u2013653","journal-title":"Cell Stress Chaperones"},{"issue":"D1","key":"5744_CR9","doi-asserted-by":"publisher","first-page":"D127","DOI":"10.1093\/nar\/gkz757","volume":"48","author":"Y Chen","year":"2020","unstructured":"Chen Y, Wang X (2020) MiRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res 48(D1):D127\u2013D131","journal-title":"Nucleic Acids Res"},{"key":"5744_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106487","volume":"185","author":"G Chen","year":"2022","unstructured":"Chen G, Zhu X, Li J, Zhang Y, Wang X, Zhang R, Qin X, Chen X, Wang J, Liao W, Wu Z, Lu L, Wu W, Yu H, Ma L (2022) Celastrol inhibits lung cancer growth by triggering histone acetylation and acting synergically with HDAC inhibitors. Pharmacol Res 185:106487","journal-title":"Pharmacol Res"},{"issue":"8","key":"5744_CR11","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adk3663","volume":"10","author":"F Chen","year":"2024","unstructured":"Chen F, Tang C, Yang F et al (2024) HSP90 inhibition suppresses tumor glycolytic flux to potentiate the therapeutic efficacy of radiotherapy for head and neck cancer. Sci Adv 10(8):eadk3663","journal-title":"Sci Adv"},{"issue":"6","key":"5744_CR12","doi-asserted-by":"publisher","first-page":"4538","DOI":"10.1002\/jcp.30172","volume":"236","author":"CH Dai","year":"2021","unstructured":"Dai CH, Zhu LR, Wang Y, Tang XP, Du YJ, Chen YC, Li J (2021) Celastrol acts synergistically with afatinib to suppress non-small cell lung cancer cell proliferation by inducing paraptosis. J Cell Physiol 236(6):4538\u20134554","journal-title":"J Cell Physiol"},{"key":"5744_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.genrep.2024.102067","volume":"37","author":"S Dasgupta","year":"2024","unstructured":"Dasgupta S (2024a) Identification and molecular modelling of potential drugs targeting the genes involved in the progression of lung cancer in patients with idiopathic pulmonary fibrosis. Gene Rep 37:102067","journal-title":"Gene Rep"},{"issue":"12","key":"5744_CR14","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1089\/omi.2024.0175","volume":"28","author":"S Dasgupta","year":"2024","unstructured":"Dasgupta S (2024b) Next-generation cancer phenomics: a transformative approach to unraveling lung cancer complexity and advancing precision medicine. OMICS 28(12):585\u2013595","journal-title":"OMICS"},{"issue":"1","key":"5744_CR15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1089\/omi.2024.0179","volume":"29","author":"S Dasgupta","year":"2025","unstructured":"Dasgupta S (2025) Multiplexed molecular endophenotypes help identify hub genes in non-small cell lung cancer: unlocking next-generation cancer phenomics. OMICS 29(1):8\u201317","journal-title":"OMICS"},{"issue":"D1","key":"5744_CR16","doi-asserted-by":"publisher","first-page":"D1257","DOI":"10.1093\/nar\/gkac833","volume":"51","author":"AP Davis","year":"2023","unstructured":"Davis AP, Wiegers TC, Johnson RJ, Sciaky D, Wiegers J, Mattingly CJ (2023) Comparative toxicogenomics database (CTD): update 2023. Nucleic Acids Res 51(D1):D1257\u2013D1262","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"5744_CR17","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"61","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt J, Santos-Martins D, Tillack AF, Forli S (2021) AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings. J Chem Inf Model 61(8):3891\u20133898","journal-title":"J Chem Inf Model"},{"issue":"1","key":"5744_CR18","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s10555-023-10136-9","volume":"43","author":"S Fakhri","year":"2024","unstructured":"Fakhri S, Moradi SZ, Faraji F, Kooshki L, Webber K, Bishayee A (2024) Modulation of hypoxia-inducible factor-1 signaling pathways in cancer angiogenesis, invasion, and metastasis by natural compounds: a comprehensive and critical review. Cancer Metastasis Rev 43(1):501\u2013574. https:\/\/doi.org\/10.1007\/s10555-023-10136-9","journal-title":"Cancer Metastasis Rev"},{"issue":"3","key":"5744_CR19","doi-asserted-by":"publisher","first-page":"3508","DOI":"10.3390\/molecules19033508","volume":"19","author":"XX Fan","year":"2014","unstructured":"Fan XX, Li N, Wu JL, Zhou YL, He JX, Liu L, Leung ELH (2014) Celastrol induces apoptosis in gefitinib-resistant non-small cell lung cancer cells via caspases-dependent pathways and Hsp90 client protein degradation. Molecules 19(3):3508\u20133522","journal-title":"Molecules"},{"issue":"17","key":"5744_CR20","doi-asserted-by":"publisher","first-page":"7773","DOI":"10.1021\/acs.jmedchem.6b00680","volume":"59","author":"J Garcia Fortanet","year":"2016","unstructured":"Garcia Fortanet J, Chen CHT, Chen YN, Chen Z, Deng Z, Firestone B, Fekkes P, Fodor M, Fortin PD, Fridrich C et al (2016) Allosteric inhibition of SHP2: identification of a potent, selective, and orally efficacious phosphatase inhibitor. J Med Chem 59(17):7773\u20137782","journal-title":"J Med Chem"},{"issue":"6","key":"5744_CR21","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","volume":"38","author":"MJ Goldman","year":"2020","unstructured":"Goldman MJ, Craft B, Hastie M, Repecka K, McDade F, Kamath A, Banerjee A, Luo Y, Rogers D, Brooks AN et al (2020) Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol 38(6):675\u2013678","journal-title":"Nat Biotechnol"},{"issue":"D1","key":"5744_CR22","doi-asserted-by":"publisher","first-page":"D222","DOI":"10.1093\/nar\/gkab1079","volume":"50","author":"HY Huang","year":"2022","unstructured":"Huang HY, Lin YCD, Cui S, Huang Y, Tang Y, Xu J, Bao J, Li Y, Wen J, Zuo H et al (2022) MiRTarBase update 2022: an informative resource for experimentally validated miRNA-target interactions. Nucleic Acids Res 50(D1):D222\u2013D230","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"5744_CR23","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/prot.25750","volume":"87","author":"JD Huck","year":"2019","unstructured":"Huck JD, Que NLS, Sharma S, Taldone T, Chiosis G, Gewirth DT (2019) Structures of Hsp90alpha and Hsp90beta bound to a purine-scaffold inhibitor reveal an exploitable residue for drug selectivity. Proteins 87(10):869\u2013877","journal-title":"Proteins"},{"issue":"D1","key":"5744_CR24","doi-asserted-by":"publisher","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","volume":"51","author":"S Kim","year":"2023","unstructured":"Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, Li Q, Shoemaker BA, Thiessen PA, Yu B et al (2023) PubChem 2023 update. Nucleic Acids Res 51(D1):D1373\u2013D1380","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"5744_CR25","first-page":"1328","volume":"52","author":"YJ Li","year":"2018","unstructured":"Li YJ, Sun YX, Hao RM, Wu P, Zhang LJ, Ma X, Ma Y, Wang PY, Xie N, Xie SY et al (2018) MiR-33a-5p enhances the sensitivity of lung adenocarcinoma cells to celastrol by regulating mTOR signaling. Int J Oncol 52(4):1328\u20131338","journal-title":"Int J Oncol"},{"issue":"1\u20133","key":"5744_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","volume":"23","author":"CA Lipinski","year":"1997","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23(1\u20133):3\u201325","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"5744_CR27","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s12672-024-01021-0","volume":"15","author":"B Liu","year":"2024","unstructured":"Liu B, Qian D (2024) Hsp90alpha and cell death in cancers: a review. Discov Oncol 15(1):151","journal-title":"Discov Oncol"},{"key":"5744_CR28","doi-asserted-by":"publisher","first-page":"11899","DOI":"10.2147\/OTT.S279434","volume":"13","author":"P Liu","year":"2020","unstructured":"Liu P, Wang M, Tang W, Li G, Gong N (2020) Circ_SATB2 attenuates the anti-tumor role of celastrol in non-small-cell lung carcinoma through targeting miR-33a-5p\/E2F7 axis. Onco Targets Ther 13:11899\u201311912","journal-title":"Onco Targets Ther"},{"issue":"8","key":"5744_CR29","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1002\/1878-0261.12936","volume":"15","author":"M Liu","year":"2021","unstructured":"Liu M, Fan Y, Li D, Han B, Meng Y, Chen F, Liu T, Song Z, Han Y, Huang L, Chang Y, Cao P, Nakai A, Tan K (2021) Ferroptosis inducer erastin sensitizes NSCLC cells to celastrol through activation of the ROS-mitochondrial fission-mitophagy axis. Mol Oncol 15(8):2084\u20132105","journal-title":"Mol Oncol"},{"issue":"6","key":"5744_CR30","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3892\/or.2023.8648","volume":"50","author":"J Liu","year":"2023","unstructured":"Liu J, Zhang F, Wang J, Wang Y (2023) MicroRNA-mediated regulation in lung adenocarcinoma: signaling pathways and potential therapeutic implications. Oncol Rep 50(6):211","journal-title":"Oncol Rep"},{"issue":"5","key":"5744_CR31","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s12272-024-01494-1","volume":"47","author":"Y Liu","year":"2024","unstructured":"Liu Y, Li C, Liu H, Tan S (2024) Combination therapy involving HSP90 inhibitors for combating cancer: an overview of clinical and preclinical progress. Arch Pharm Res 47(5):442\u2013464. https:\/\/doi.org\/10.1007\/s12272-024-01494-1","journal-title":"Arch Pharm Res"},{"issue":"18","key":"5744_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e37739","volume":"10","author":"Z Lu","year":"2024","unstructured":"Lu Z, Bi Y, Jiang J, Yao X, Hou G (2024) Exploring the prognostic and therapeutic value of HIF1A in lung adenocarcinoma. Heliyon 10(18):e37739","journal-title":"Heliyon"},{"issue":"8","key":"5744_CR33","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1093\/bioinformatics\/btv701","volume":"32","author":"A Luna","year":"2016","unstructured":"Luna A, Rajapakse VN, Sousa FG, Gao J, Schultz N, Varma S, Reinhold W, Sander C, Pommier Y (2016) Rcellminer: exploring molecular profiles and drug response of the NCI-60 cell lines in R. Bioinformatics 32(8):1272\u20131274","journal-title":"Bioinformatics"},{"issue":"6","key":"5744_CR34","first-page":"1291","volume":"13","author":"A Mogavero","year":"2023","unstructured":"Mogavero A, Bironzo P, Righi L, Merlini A, Benso F, Novello S, Passiglia F (2023) Deciphering lung adenocarcinoma heterogeneity: an overview of pathological and clinical features of rare subtypes. Life (Basel) 13(6):1291","journal-title":"Life (Basel)"},{"issue":"2","key":"5744_CR35","first-page":"984","volume":"19","author":"UM Nazim","year":"2019","unstructured":"Nazim UM, Yin H, Park SY (2019) Autophagy flux inhibition mediated by celastrol sensitized lung cancer cells to TRAIL-induced apoptosis via regulation of mitochondrial transmembrane potential and reactive oxygen species. Mol Med Rep 19(2):984\u2013993","journal-title":"Mol Med Rep"},{"issue":"W1","key":"5744_CR36","doi-asserted-by":"publisher","first-page":"W83","DOI":"10.1093\/nar\/gkw199","volume":"44","author":"J Reimand","year":"2016","unstructured":"Reimand J, Arak T, Adler P, Kolberg L, Reisberg S, Peterson H, Vilo J (2016) g:Profiler-a web server for functional interpretation of gene lists (2016 update). Nucleic Acids Res 44(W1):W83\u2013W89","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"5744_CR37","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/s41596-018-0103-9","volume":"14","author":"J Reimand","year":"2019","unstructured":"Reimand J, Isserlin R, Voisin V, Kucera M, Tannus-Lopes C, Rostamianfar A, Wadi L, Meyer M, Wong J, Xu C et al (2019) Pathway enrichment analysis and visualization of omics data using g:Profiler, GSEA, Cytoscape and EnrichmentMap. Nat Protoc 14(2):482\u2013517","journal-title":"Nat Protoc"},{"issue":"14","key":"5744_CR38","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1158\/0008-5472.CAN-12-1370","volume":"72","author":"WC Reinhold","year":"2012","unstructured":"Reinhold WC, Sunshine M, Liu H, Varma S, Kohn KW, Morris J, Doroshow J, Pommier Y (2012) Cell miner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set. Cancer Res 72(14):3499\u20133511","journal-title":"Cancer Res"},{"issue":"1","key":"5744_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166924","volume":"1870","author":"J Slanovc","year":"2024","unstructured":"Slanovc J, Mikulcic M, Jahn N et al (2024) Prostaglandin 15d-PGJ2 inhibits proliferation of lung adenocarcinoma cells by inducing ROS production and activation of apoptosis via sirtuin-1. Biochim Biophys Acta Mol Basis Dis 1870(1):166924","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"3","key":"5744_CR40","first-page":"209","volume":"71","author":"H Sung","year":"2020","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2020) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"issue":"D1","key":"5744_CR41","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, Gable AL, Fang T, Doncheva NT, Pyysalo S et al (2023) The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res 51(D1):D638\u2013D646","journal-title":"Nucleic Acids Res"},{"key":"5744_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122890","volume":"352","author":"N Taneja","year":"2024","unstructured":"Taneja N, Chauhan A, Kulshreshtha R, Singh S (2024) HIF-1 mediated metabolic reprogramming in cancer: mechanisms and therapeutic implications. Life Sci 352:122890","journal-title":"Life Sci"},{"issue":"2","key":"5744_CR43","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) AutoDock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31(2):455\u2013461","journal-title":"J Comput Chem"},{"issue":"12","key":"5744_CR44","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"DF Veber","year":"2002","unstructured":"Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD (2002) Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 45(12):2615\u20132623","journal-title":"J Med Chem"},{"issue":"7893","key":"5744_CR45","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41586-021-04252-1","volume":"601","author":"RYR Wang","year":"2022","unstructured":"Wang RYR, Noddings CM, Kirschke E, Myasnikov AG, Johnson JL, Agard DA (2022) Structure of Hsp90-Hsp70-Hop-GR reveals the Hsp90 client-loading mechanism. Nature 601(7893):460\u2013464","journal-title":"Nature"},{"key":"5744_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114882","volume":"163","author":"C Wang","year":"2023","unstructured":"Wang C, Dai S, Zhao X, Zhang Y, Gong L, Fu K, Ma C, Peng C, Li Y (2023a) Celastrol as an emerging anticancer agent: current status, challenges and therapeutic strategies. Biomed Pharmacother 163:114882","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"5744_CR47","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s00204-023-03476-6","volume":"97","author":"B Wang","year":"2023","unstructured":"Wang B, Wang Y, Zhang J, Hu C, Jiang J, Li Y, Peng Z (2023b) ROS-induced lipid peroxidation modulates cell death outcome: mechanisms behind apoptosis, autophagy, and ferroptosis. Arch Toxicol 97(6):1439\u20131451","journal-title":"Arch Toxicol"},{"issue":"1","key":"5744_CR48","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12885-022-09296-8","volume":"22","author":"S Wen","year":"2022","unstructured":"Wen S, Peng W, Chen Y, Du X, Xia J, Shen B, Zhou G (2022) Four differentially expressed genes can predict prognosis and microenvironment immune infiltration in lung cancer: a study based on data from the GEO. BMC Cancer 22(1):193","journal-title":"BMC Cancer"},{"issue":"43","key":"5744_CR49","doi-asserted-by":"publisher","first-page":"43697","DOI":"10.1021\/acsomega.4c06152","volume":"9","author":"C Xu","year":"2024","unstructured":"Xu C, Chen Y, Zhou Z, Yan Y, Fu W, Zou P, Ni D (2024) ML385, an Nrf2 inhibitor, synergically enhanced celastrol-triggered endoplasmic reticulum stress in lung cancer cells. ACS Omega 9(43):43697\u201343705","journal-title":"ACS Omega"},{"issue":"2","key":"5744_CR50","first-page":"2515","volume":"15","author":"YF Yan","year":"2018","unstructured":"Yan YF, Zhang HH, Lv Q, Liu YM, Li YJ, Li BS, Wang PY, Shang WJ, Yue Z, Xie SY (2018) Celastrol suppresses the proliferation of lung adenocarcinoma cells by regulating microRNA-24 and microRNA-181b. Oncol Lett 15(2):2515\u20132521","journal-title":"Oncol Lett"},{"issue":"12","key":"5744_CR51","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1080\/15384101.2023.2216504","volume":"22","author":"B Yu","year":"2023","unstructured":"Yu B, Zhou Y, He J (2023) TRIM13 inhibits cell proliferation and induces autophagy in lung adenocarcinoma by regulating KEAP1\/NRF2 pathway. Cell Cycle 22(12):1496\u20131513","journal-title":"Cell Cycle"},{"key":"5744_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1451230","volume":"14","author":"L Yu","year":"2024","unstructured":"Yu L, Yang R, Long Z, Tao Q, Liu B (2024) Targeted therapy of non-small cell lung cancer: mechanisms and clinical trials. Front Oncol 14:1451230","journal-title":"Front Oncol"},{"issue":"D1","key":"5744_CR53","doi-asserted-by":"publisher","first-page":"D1180","DOI":"10.1093\/nar\/gkad1004","volume":"52","author":"B Zdrazil","year":"2024","unstructured":"Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Mendez Lopez D, Mosquera JF et al (2024) The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res 52(D1):D1180\u2013D1192","journal-title":"Nucleic Acids Res"},{"key":"5744_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1420643","volume":"15","author":"X Zhang","year":"2024","unstructured":"Zhang X, Yu D, Tang P, Chen F (2024a) Insights into the role of mitophagy in lung cancer: current evidence and perspectives. Front Pharmacol 15:1420643","journal-title":"Front Pharmacol"},{"issue":"2","key":"5744_CR55","doi-asserted-by":"publisher","DOI":"10.3892\/or.2023.8688","volume":"51","author":"F Zhang","year":"2024","unstructured":"Zhang F, Qi Y, Li J, Liu B, Liu Z, Cui X (2024b) Activin A induces apoptosis of human lung adenocarcinoma A549 cells through endoplasmic reticulum stress pathway. Oncol Rep 51(2):29","journal-title":"Oncol Rep"},{"key":"5744_CR56","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.lungcan.2020.09.014","volume":"149","author":"J Zhao","year":"2020","unstructured":"Zhao J, Guo C, Ma Z, Liu H, Yang C, Li S (2020) Identification of a novel gene expression signature associated with overall survival in patients with lung adenocarcinoma: a comprehensive analysis based on TCGA and GEO databases. Lung Cancer 149:90\u201396","journal-title":"Lung Cancer"},{"key":"5744_CR57","volume":"81","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Miettinen K, Kampranis SC (2024) Celastrol: a century-long journey from the isolation to the biotechnological production and the development of an antiobesity drug. Curr Opin Biotechnol 81:102615","journal-title":"Curr Opin Biotechnol"},{"issue":"5","key":"5744_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0299921","volume":"19","author":"J Zhong","year":"2024","unstructured":"Zhong J, Hua Y, Zou S, Wang B (2024) Juglone triggers apoptosis of non-small cell lung cancer through the reactive oxygen species-mediated PI3K\/Akt pathway. PLoS ONE 19(5):e0299921","journal-title":"PLoS ONE"},{"issue":"1","key":"5744_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0262931","volume":"17","author":"J Zhou","year":"2022","unstructured":"Zhou J, Guo H, Zhang Y, Liu H, Dou Q (2022) Prognostic significance of SHP2 (PTPN11) expression in solid tumors: a meta-analysis. PLoS ONE 17(1):e0262931","journal-title":"PLoS ONE"},{"key":"5744_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176387","volume":"967","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Dai Z (2024) HSP90: a promising target for NSCLC treatments. Eur J Pharmacol 967:176387","journal-title":"Eur J Pharmacol"},{"issue":"14","key":"5744_CR61","doi-asserted-by":"publisher","first-page":"5510","DOI":"10.7150\/ijbs.99592","volume":"20","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Meng Y, Zhang J, Liu R, Shen S, Gu L, Wong YK, Ma A, Chai X, Zhang Y et al (2024) Recent trends in anti-tumor mechanisms and molecular targets of celastrol. Int J Biol Sci 20(14):5510\u20135530","journal-title":"Int J Biol Sci"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05744-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05744-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05744-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:01:31Z","timestamp":1792886491000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05744-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":61,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["5744"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05744-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9883855\/v1","asserted-by":"object"}]},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,25]]},"assertion":[{"value":"1 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study used publicly available deidentified datasets and established human LUAD cell lines. It did not recruit human participants, collect identifiable personal information, or involve animal experiments. Institutional ethics approval and informed consent were therefore not required.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":4,"name":"Ethics","label":"Use of automated tools","group":{"name":"EthicsHeading","label":"Declarations"}}]}}